DiaMedica Therapeutics (DMAC) Interest & Investment Income (2019 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Interest & Investment Income came in at -$76000.0 in Q1 2026, down 322.22% year-on-year from $34200.0 in Q1 2025, and up 93.5% quarter-over-quarter from -$1.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest & Investment Income (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$76000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 322.22% year-over-year to -$76000.0 in Q1 2026; TTM through Mar 2026 was -$825000.0, a 135.44% decrease from a year earlier, with the FY2025 full-year figure at $27000.0, down 98.83% from the prior year.
- Interest & Investment Income grew to -$76000.0 in Q1 2026 per DMAC's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q4 2024 and bottomed at -$1.2 million in Q4 2025.
- The 5-year median for Interest & Investment Income is -$18000.0 (2025), against an average of $199176.5.
- Across the five-year window, Interest & Investment Income slumped 6100.0% in 2022 and soared 2177.27% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $88000.0 in 2022, then surged by 2177.27% to $2.0 million in 2023, then grew by 11.08% to $2.2 million in 2024, then sank by 152.56% to -$1.2 million in 2025, then soared by 93.5% to -$76000.0 in 2026.
- Per Business Quant, the three latest DMAC Interest & Investment Income figures stand at -$76000.0 (Q1 2026), -$1.2 million (Q4 2025), and $440000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | -76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | 440,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -34,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 88,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -60,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -46,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | 1,000.00 |